Streetbeat News

Stock Prices

COP

ConocoPhillips Inc. (NYSE:COP) stock has seen a 0.25% increase in the current session, trading at $126.54. Over the past month and year, the stock has risen by 12.94% and 26.37%, respectively. Its P/E ratio of 13.93 is higher than the industry average of 12.51, suggesting it might be overvalued or expected to outperform its peers in the Oil, Gas & Consumable Fuels industry.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 6:45 pm

AMD

INTC

NVDA

SMH

SOXL

SOXX

China's new guidelines phasing out foreign microprocessors in government PCs and servers have caused volatility in semiconductor stocks, including AMD and Intel. Semiconductor ETFs like SMH, SOXX, and SOXL also experienced volatility. Despite this, Intel is highlighted for its favorable fundamentals compared to Nvidia, AMD, and Micron, with better P/E, Price/Sales, and EV/Sales ratios. However, Intel's technical indicators suggest a mixed outlook, with a bearish short-term trend but potential for medium to long-term growth.

Portfolio Pulse from Surbhi Jain

March 26, 2024 | 6:45 pm

NBSE

NeuBase Therapeutics Inc (NASDAQ:NBSE) shares plummeted by 53% to $0.47 after announcing a Special Meeting of Stockholders to vote on the company's proposed liquidation and dissolution. The Board of Directors recommends approval of these proposals. The meeting is set for May 13, online, with registration required by May 12. The company does not pay dividends or have recent buyback programs. NBSE's 52-week trading range is between $0.59 and $5.40.

Portfolio Pulse from Henry Khederian

March 26, 2024 | 6:43 pm

CDLX

Cardlytics Inc (NASDAQ:CDLX) shares plummeted 34.6% to $13.24 after announcing a $150 million convertible senior notes offering. The notes, due in 2029, aim to fund the repurchase of existing notes and for general corporate purposes. The offering and potential unwind transactions could impact the market price of Cardlytics' common stock.

Portfolio Pulse from Henry Khederian

March 26, 2024 | 6:42 pm

ACB

IMCC

LFLY

SNDL

Cannabis stocks are experiencing an uptick following the German government's approval of cannabis legalization, indicating continued strength in the sector.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:40 pm

JNJ

SWAV

Shockwave Medical's stock price has increased following news that Johnson & Johnson is reportedly in discussions to acquire the company.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:37 pm

MRK

SMMT

Stifel initiated coverage on Summit Therapeutics (SMMT) with a Buy rating and a price target of $8, highlighting ivonescimab's potential in lung cancer treatment. Ivonescimab, in phase 3 trials, could challenge Merck's (MRK) Keytruda. Akeso out-licensed ivonescimab to Summit for up to $5 billion. Positive phase 1/2 data and strategic trial designs boost confidence in ivonescimab's success. SMMT shares rose 13.7% to $3.73.

Portfolio Pulse from Vandana Singh

March 26, 2024 | 6:36 pm

DWAC

Trump Media & Technology Group (TMTG) went public through a merger with Digital World Acquisition Corporation (NASDAQ:DWAC), despite facing multiple setbacks including shareholder vote delays, investigations, and legal actions. Market experts view TMTG as a 'meme stock' and a way to bet on or against Trump rather than its underlying business. The stock saw a 37% increase on its debut day, with shares hitting new 52-week highs. Trump, owning 80 million shares, faces a six-month lockup, with speculation about potential share sales to free up capital.

Portfolio Pulse from Chris Katje

March 26, 2024 | 6:36 pm

VERI

Veritone shares are trading higher following the company's announcement of Ask Veri.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 6:35 pm

HUM

Over the past 10 years, Humana (NYSE:HUM) has outperformed the market with an average annual return of 11.89%, turning a $100 investment into $309.16 today. Humana's market capitalization currently stands at $42.01 billion.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 6:30 pm